Literature DB >> 15724449

Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway.

Z C Dang1, C W G M Lowik.   

Abstract

In vitro differentiation of the progenitor cells or preadipocytes into adipocytes is usually achieved by adding an adipogenic mixture (isobutylmethylxanthine, dexamethasone, and insulin, IDI) to medium supplemented with fetal bovine serum (FBS). To study the effects of steroid hormones in vitro, endogenous hormones, growth factors and cytokines are removed by charcoal stripping of serum. However, the effects of charcoal-stripped serum (CS-FBS) per se on adipogenesis have been ignored. Here, we showed that alkaline phosphate activity and nodule formation of osteoprogenitor KS483 cells were lower in CS-FBS than in FBS. Concurrently, abundant amounts of adipocytes were only observed in KS483 cells cultured with CS-FBS, irrespective of the brands of serum used. Inhibition of the p42/44 MAPK pathway by its specific inhibitor PD98059 increased adipogenesis of KS483 cells with FBS, whereas activation of this signalling pathway by EGF blocked adipogenesis of these cells with CS-FBS. Furthermore, the p42/44 MAPK phosphorylation of KS483 cells cultured with CS-FBS was decreased compared with FBS. We concluded that charcoal-stripping of serum removed stimulators of the MAPK signalling pathway and in turn led to downregulation of osteogenesis and upregulation of adipogenesis. Interestingly, the adipogenic mixture IDI stimulated adipogenesis of KS483 cells cultured with CS-FBS, but not with FBS. Furthermore, differential effects of genistein on adipogenesis were observed in KS483 cells cultured with FBS or CS-FBS in combination with IDI. Our results showed that charcoal stripping of serum affected the commitment of KS483 cells and therefore differentially regulated adipogenesis influenced by IDI alone and in combination with genistein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15724449     DOI: 10.1007/s11010-005-3857-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

2.  A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse.

Authors:  J E Dennis; A Merriam; A Awadallah; J U Yoo; B Johnstone; A I Caplan
Journal:  J Bone Miner Res       Date:  1999-05       Impact factor: 6.741

3.  Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.

Authors:  M Adams; M J Reginato; D Shao; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

4.  Identification of amino acid residues of Gsalpha critical to repression of adipogenesis.

Authors:  X Liu; C C Malbon; H Y Wang
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

5.  Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.

Authors:  H S Camp; S R Tafuri
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

6.  Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.

Authors:  T Yamashita; K Asano; N Takahashi; T Akatsu; N Udagawa; T Sasaki; T J Martin; T Suda
Journal:  J Cell Physiol       Date:  1990-12       Impact factor: 6.384

7.  Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.

Authors:  E Hu; J B Kim; P Sarraf; B M Spiegelman
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  Role of serum in the developmental expression of alkaline phosphatase in MC3T3-E1 osteoblasts.

Authors:  D A Yohay; J Zhang; K M Thrailkill; J M Arthur; L D Quarles
Journal:  J Cell Physiol       Date:  1994-03       Impact factor: 6.384

9.  Charcoal-dextran treatment of fetal bovine serum removes an inhibitor of human CFU-megakaryocytes.

Authors:  D L Lindquist; P A de Alarcon
Journal:  Exp Hematol       Date:  1987-03       Impact factor: 3.084

10.  Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages.

Authors:  D Chen; X Ji; M A Harris; J Q Feng; G Karsenty; A J Celeste; V Rosen; G R Mundy; S E Harris
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

View more
  11 in total

1.  Thermally labile components of aqueous humor potently induce osteogenic potential in adipose-derived mesenchymal stem cells.

Authors:  Joshua T Morgan; Heung Sun Kwon; Joshua A Wood; Dori L Borjesson; Stanislav I Tomarev; Christopher J Murphy; Paul Russell
Journal:  Exp Eye Res       Date:  2015-02-24       Impact factor: 3.467

2.  A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion.

Authors:  Archis Bagati; Zethan Koch; Diane Bofinger; Haneesha Goli; Laura S Weiss; Rosie Dau; Megha Thomas; Shoshanna N Zucker
Journal:  J Vis Exp       Date:  2015-04-24       Impact factor: 1.355

3.  Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation.

Authors:  Yuhui Wang; Hei Sook Sul
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Ethical Challenges Using Human Tumor Cell Lines in Cancer Research.

Authors:  Wilhelm G Dirks
Journal:  Recent Results Cancer Res       Date:  2021

5.  Testosterone upregulates anion secretion across porcine vas deferens epithelia in vitro.

Authors:  Fernando Pierucci-Alves; Cameron L Duncan; Bruce D Schultz
Journal:  Biol Reprod       Date:  2009-05-27       Impact factor: 4.285

6.  Thyroid hormone inactivation in gastrointestinal stromal tumors.

Authors:  Michelle A Maynard; Adrian Marino-Enriquez; Jonathan A Fletcher; David M Dorfman; Chandrajit P Raut; Leila Yassa; Cuicui Guo; Yuexiang Wang; Clara Dorfman; Henry A Feldman; Mary C Frates; Huaidong Song; Rebecca H Jugo; Takahiro Taguchi; Jerome M Hershman; P Reed Larsen; Stephen A Huang
Journal:  N Engl J Med       Date:  2014-04-03       Impact factor: 91.245

7.  Estrogen prevents articular cartilage destruction in a mouse model of AMPK deficiency via ERK-mTOR pathway.

Authors:  Yuxiang Ge; Sheng Zhou; Yixuan Li; Zixu Wang; Shuai Chen; Tianwei Xia; Jirong Shen; Huajian Teng; Qing Jiang
Journal:  Ann Transl Med       Date:  2019-07

8.  Relationships between serum-induced AhR bioactivity or mitochondrial inhibition and circulating polychlorinated biphenyls (PCBs).

Authors:  Wook Ha Park; Sora Kang; Hong Kyu Lee; Samira Salihovic; Bert van Bavel; P Monica Lind; Youngmi Kim Pak; Lars Lind
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

9.  Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells.

Authors:  Ranjit S Bindra; Alexander G Goglia; Maria Jasin; Simon N Powell
Journal:  Nucleic Acids Res       Date:  2013-04-12       Impact factor: 19.160

10.  hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen.

Authors:  Jennifer A Fraser; Joseph E Sutton; Saba Tazayoni; Isla Bruce; Amy V Poole
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.